PDE4D and psoriasis: Increased ERK activity can lead on the one hand to induce cell proliferation and inhibit cell apoptosis, and on the other hand to increase PDE4D activation, leading to there was no therapeutic synergy between salmeterol and roflumilast in relieving psoriasis.